Policewoman gets lover’s hand chopped. Reason: He was hesitating to become her second hubby!

Thiruvananthapuram, Mar 29: Twenty more people were

detected with coronavirus in Kerala on Saturday, taking the total number of those undergoing treatment for the deadly infection to 181, Health Minister K K Shailaja said.

While Kannur reported eight cases, Kasaragod 7, Thiruvananthapuram, Ernkulam, Thrissur, Palakad and Malappuram reported one case each, Shailaja said in a statement here.

Of the 20 people, 18 had come from abroad and two others had been infected through contact.

The man found positive here was in the isolation ICU of the Thiruvananthapuram Medical College hospital, while one positive case from Ernakulam was a health worker.

The samples of four persons who were under treatment at Pathnamthitta were found negative.

At least, 1,41,211 people are under observation across the state, the Minister addd.

Mangaluru, June 11: The private flight chartered by Saudi Arabia's SAQCO Contracting Company to repatriate coastal Kannadigas stranded in the kingdom landed at Mangaluru International Airport at 1:15 am on Wednesday.

The flight with 175 passengers took off from the Dammam International Airport around 6 pm (KSA time).

SAQCO’s Directors Althaf Ullal and Basheer Sagar said that all the legal procedures were carried out smoothly before the flight took off from Dammam for Mangaluru.

The duo also informed that no staff or official of SAQCO were traveling on the chartered flight and that it was arranged only for the stranded Kannadigas. The cost of traveling, institutional quarantine, and COVID-19 tests will be borne by the SAQCO Company.

SAQCO had established a desk to finalize the list of passengers who will be traveling on the flight to Mangaluru on Wednesday. The company added priority was given to pregnant women, the senior citizens who had come to the kingdom on visit visas, people with medical emergencies, people who had lost jobs, and those who had reported deaths in their families.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.